MedPath

Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration

Completed
Conditions
Age-Related Macular Degeneration
Registration Number
NCT02422160
Lead Sponsor
Stanford University
Brief Summary

The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practice on each patient visit to the ophthalmologist. The investigators' goal is to evaluate whether this method will improve the ability to detect AMD earlier and improve visual outcomes in AMD patients by assigning patient risk categories and having patients come back for follow up based on those categories.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Non-exudative age-related macular degeneration
Read More
Exclusion Criteria
  • Exudative age-related macular degeneration
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual AcuityTwo Years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Byers Eye Institute at Stanford

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath